Publications database

Displaying 1 - 10 of 10

Cover of the foresight toolkit guide

How to run a trends workshop: An EMCDDA foresight toolkit for the drugs field

This toolkit aims to support the EMCDDA’s stakeholders, other actors and researchers in the drugs field to implement their own foresight exercise in the form of an introductory trend-based workshop. It describes...

Publication cover

EMCDDA guide to holding a stakeholder round-table on supporting hepatitis C testing and care in drug services

This guide is aimed at supporting teams organising stakeholder round-table meetings as part of their regional or national diagnostic processes aimed at identifying barriers to and opportunities to increase hepatitis C virus...

Cover page of risk assessment guidelines

EMCDDA operating guidelines for the risk assessment of new psychoactive substances

The purpose of these guidelines is to ensure compliance with the scope and requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 2004/757/JHA (as amended) in respect to the...

Screenshot of publication in HTML format. Titles says 'Communicating results of wastewater-based epidemiology applied to illicit drugs: the do’s and don’ts'

Communicating results of wastewater-based epidemiology applied to illicit drugs: the do’s and don’ts

Wastewater-based epidemiology (WBE) is a rapidly developing scientific discipline with potential for monitoring real-time data on geographical and temporal trends in illicit drug use, which established itself as a useful complement to...

Publication cover_EWS guidelines

EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances

These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System. They reflect the requirements of Regulation (EC) No 1920/2006 (as amended) and Council...

Financial regulation of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

This regulation lays down the essential financial rules for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). It is based on and does not depart from the Commission Delegated Regulation...

publication cover

Drug-related infectious diseases (DRID) toolkit

The toolkit is designed to help health professionals improve their monitoring practice in order to reduce the burden of disease in this vulnerable group and improve the coverage and quality of services...

Risk assessment of new psychoactive substances — operating guidelines

The principal aim of these guidelines is to put in place a sound methodological and procedural basis for carrying out each risk assessment, by using a semi-quantitative assessment procedure. This publication is...

Early-warning system on new psychoactive substances — operating guidelines

These practical guidelines have been published to assist the implementation of the Council decision on information exchange, risk-assessment and control of new psychoactive substances. They deal with phase 1 of the measures...

Guidelines for the risk assessment of new synthetic drugs

This publication was drawn up by the steering group created by the EMCDDA's Scientific Committee in November 1998 to establish guidelines to assess the risks of all new synthetic drugs identified under...